Aplastic anemia: management of pediatric patients.
Aplastic anemia is a term describing the common findings of pancytopenia and marrow hypoplasia arising from a variety of disease states, including acquired aplastic anemia and a variety of congenital marrow failure states. The management of children with these disorders has been confounded by difficulties of diagnosis. The availability of molecular testing has assisted in partial resolution of this problem but has raised new issues, such as the potential of genetic predisposition and the management of asymptomatic individuals with molecular markers. Longitudinal data from large cohort studies and disease registries are providing a rational basis for making more informed treatment decisions for children with these disorders. In particular, the ability to subset patients more accurately has improved triage of treatments. Approaches to hematopoietic stem cell transplantation (SCT), using both conventional and alternative donors, are changing rapidly, and the long-term sequelae of newer approaches are not entirely clear. Improved diagnosis and longer survival have fostered an understanding of the multidisciplinary approach necessary to manage both the underlying problems and the significant sequelae of treatment in both acquired and congenital disease.
Guinan
Eva C
EC
Dana-Farber Cancer Inst., 44 Binney Street, Room D354, Boston, MA 02115, USA. eva_guinan@dfci.harvard.edu
D000293:Adolescent; D000741:Anemia, Aplastic / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D001772:Blood Cell Count; D001803:Blood Transfusion; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D015331:Cohort Studies; D019317:Evidence-Based Medicine; D006086:Graft vs Host Disease / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D017713:Platelet Transfusion; D011627:Puberty; D012042:Registries; D055815:Young Adult